Key statistics
As of last trade MannKind Corp (NNFN:DUS) traded at 3.18, 0.16% above its 52-week low of 3.17, set on Jun 16, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.18 |
---|---|
High | 3.18 |
Low | 3.18 |
Bid | 3.13 |
Offer | 3.18 |
Previous close | 3.19 |
Average volume | 0.00 |
---|---|
Shares outstanding | 303.93m |
Free float | 270.74m |
P/E (TTM) | 38.35 |
Market cap | 1.14bn USD |
EPS (TTM) | 0.098 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 07:11 BST.
More ▼
Announcements
- MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
- MannKind to Present at Upcoming Investor Conferences
- MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
- MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
- MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
- MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
- MannKind to Present at Upcoming Investor Conferences
- MannKind Expands Executive Leadership Team
- MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash
More ▼